Fig. 1.
Kinetics of the neutralizing antibodies in breast cancer patients receiving CDK4/6 inhibitors and matched controls, following the first dose of the BNT162b2, AZD1222, mRNA-1273 vaccines.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.